Literature DB >> 24803391

Oral epithelial stem cells - implications in normal development and cancer metastasis.

Silvana Papagerakis1, Giuseppe Pannone2, Li Zheng3, Imad About4, Nawar Taqi5, Nghia P T Nguyen6, Margarite Matossian6, Blake McAlpin3, Angela Santoro2, Jonathan McHugh7, Mark E Prince6, Petros Papagerakis8.   

Abstract

Oral mucosa is continuously exposed to environmental forces and has to be constantly renewed. Accordingly, the oral mucosa epithelium contains a large reservoir of epithelial stem cells necessary for tissue homeostasis. Despite considerable scientific advances in stem cell behavior in a number of tissues, fewer studies have been devoted to the stem cells in the oral epithelium. Most of oral mucosa stem cells studies are focused on identifying cancer stem cells (CSC) in oral squamous cell carcinomas (OSCCs) among other head and neck cancers. OSCCs are the most prevalent epithelial tumors of the head and neck region, marked by their aggressiveness and invasiveness. Due to their highly tumorigenic properties, it has been suggested that CSC may be the critical population of cancer cells in the development of OSCC metastasis. This review presents a brief overview of epithelium stem cells with implications in oral health, and the clinical implications of the CSC concept in OSCC metastatic dissemination.
Copyright © 2014. Published by Elsevier Inc.

Entities:  

Keywords:  Cancer stem cells; Epithelial stem cells; Invasion; Metastasis; Oral mucosa; Oral squamous cell carcinoma

Mesh:

Year:  2014        PMID: 24803391      PMCID: PMC4157336          DOI: 10.1016/j.yexcr.2014.04.021

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  213 in total

1.  Circadian variation in the expression of cell-cycle proteins in human oral epithelium.

Authors:  G A Bjarnason; R C Jordan; R B Sothern
Journal:  Am J Pathol       Date:  1999-02       Impact factor: 4.307

Review 2.  Head and neck cancer stem cells.

Authors:  S Krishnamurthy; J E Nör
Journal:  J Dent Res       Date:  2011-09-20       Impact factor: 6.116

3.  Significance of mTOR signaling and its inhibitor against cancer stem-like cells in colorectal cancer.

Authors:  Zerong Cai; Jia Ke; Xiaosheng He; Ruixue Yuan; Yufeng Chen; Xianrui Wu; Lei Wang; Jianping Wang; Ping Lan; Xiaojian Wu
Journal:  Ann Surg Oncol       Date:  2013-08-02       Impact factor: 5.344

Review 4.  Distant metastases from head and neck squamous cell carcinoma. Part III. Treatment.

Authors:  Missak Haigentz; Dana M Hartl; Carl E Silver; Johannes A Langendijk; Primož Strojan; Vinidh Paleri; Remco de Bree; Jean-Pascal Machiels; Marc Hamoir; Alessandra Rinaldo; Daniela Paccagnella; Ashok R Shaha; Robert P Takes; Alfio Ferlito
Journal:  Oral Oncol       Date:  2012-04-18       Impact factor: 5.337

Review 5.  Molecular pathways: current role and future directions of the retinoic acid pathway in cancer prevention and treatment.

Authors:  Roisin M Connolly; Nguyen K Nguyen; Saraswati Sukumar
Journal:  Clin Cancer Res       Date:  2013-01-15       Impact factor: 12.531

Review 6.  Exploring a new twist on tumor metastasis.

Authors:  Jing Yang; Sendurai A Mani; Robert A Weinberg
Journal:  Cancer Res       Date:  2006-05-01       Impact factor: 12.701

7.  Wnt isoform-specific interactions with coreceptor specify inhibition or potentiation of signaling by LRP6 antibodies.

Authors:  Yan Gong; Eric Bourhis; Cecilia Chiu; Scott Stawicki; Venita I DeAlmeida; Bob Y Liu; Khanhky Phamluong; Tim C Cao; Richard A D Carano; James A Ernst; Mark Solloway; Bonnee Rubinfeld; Rami N Hannoush; Yan Wu; Paul Polakis; Mike Costa
Journal:  PLoS One       Date:  2010-09-13       Impact factor: 3.240

8.  In vitro evaluation of sialyl Lewis X relationship with head and neck cancer stem cells.

Authors:  Michael J Czerwinski; Vincenzo Desiderio; Omar Shkeir; Petros Papagerakis; Martian C Lapadatescu; John H Owen; Maria Athanassiou-Papaefthymiou; Li Zheng; Gianpaolo Papaccio; Mark E Prince; Silvana Papagerakis
Journal:  Otolaryngol Head Neck Surg       Date:  2013-04-04       Impact factor: 3.497

Review 9.  The tumor microenvironment and its role in promoting tumor growth.

Authors:  T L Whiteside
Journal:  Oncogene       Date:  2008-10-06       Impact factor: 9.867

10.  Resveratrol inhibits alpha-melanocyte-stimulating hormone signaling, viability, and invasiveness in melanoma cells.

Authors:  Yu-Jen Chen; Ying-Yin Chen; Yi-Feng Lin; Hsuan-Yun Hu; Hui-Fen Liao
Journal:  Evid Based Complement Alternat Med       Date:  2013-05-23       Impact factor: 2.629

View more
  15 in total

Review 1.  Open questions and novel concepts in oral cancer surgery.

Authors:  Giancarlo Tirelli; Serena Zacchigna; Matteo Biasotto; Marco Piovesana
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-05-24       Impact factor: 2.503

2.  Association of TGFβ signaling with the maintenance of a quiescent stem cell niche in human oral mucosa.

Authors:  Claudia D Andl; Grégoire F Le Bras; Holli Loomans; Annette S Kim; Linli Zhou; Yuhang Zhang; Thomas Andl
Journal:  Histochem Cell Biol       Date:  2016-08-02       Impact factor: 4.304

Review 3.  Squamous Cell Cancers: A Unified Perspective on Biology and Genetics.

Authors:  G Paolo Dotto; Anil K Rustgi
Journal:  Cancer Cell       Date:  2016-05-09       Impact factor: 31.743

4.  Heterogeneity within Stratified Epithelial Stem Cell Populations Maintains the Oral Mucosa in Response to Physiological Stress.

Authors:  Kevin M Byrd; Natalie C Piehl; Jeet H Patel; Won Jae Huh; Inês Sequeira; Kendall J Lough; Bethany L Wagner; Pauline Marangoni; Fiona M Watt; Ophir D Klein; Robert J Coffey; Scott E Williams
Journal:  Cell Stem Cell       Date:  2019-12-05       Impact factor: 24.633

5.  Clinical significance of kallikrein-related peptidase-4 in oral cancer.

Authors:  Petros Papagerakis; Giuseppe Pannone; L I Zheng; Maria Athanassiou-Papaefthymiou; Yashuo Yamakoshi; Howard Stan McGuff; Omar Shkeir; Konstantinos Ghirtis; Silvana Papagerakis
Journal:  Anticancer Res       Date:  2015-04       Impact factor: 2.480

6.  Metabolic Reprogramming and Dependencies Associated with Epithelial Cancer Stem Cells Independent of the Epithelial-Mesenchymal Transition Program.

Authors:  Esther Aguilar; Igor Marin de Mas; Erika Zodda; Silvia Marin; Fionnuala Morrish; Vitaly Selivanov; Óscar Meca-Cortés; Hossain Delowar; Mònica Pons; Inés Izquierdo; Toni Celià-Terrassa; Pedro de Atauri; Josep J Centelles; David Hockenbery; Timothy M Thomson; Marta Cascante
Journal:  Stem Cells       Date:  2016-02-02       Impact factor: 6.277

7.  TERT promoter hotspot mutations and their relationship with TERT levels and telomere erosion in patients with head and neck squamous cell carcinoma.

Authors:  Paolo Boscolo-Rizzo; Silvia Giunco; Enrica Rampazzo; Martina Brutti; Giacomo Spinato; Anna Menegaldo; Marco Stellin; Monica Mantovani; Luigia Bandolin; Marco Rossi; Annarosa Del Mistro; Giancarlo Tirelli; Angelo Paolo Dei Tos; Angela Guerriero; Monia Niero; Maria Cristina Da Mosto; Jerry Polesel; Anita De Rossi
Journal:  J Cancer Res Clin Oncol       Date:  2020-01-20       Impact factor: 4.553

8.  Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells.

Authors:  Alexandra Iulia Irimie; Cornelia Braicu; Oana Zanoaga; Valentina Pileczki; Claudia Gherman; Ioana Berindan-Neagoe; Radu Septimiu Campian
Journal:  Onco Targets Ther       Date:  2015-02-20       Impact factor: 4.147

Review 9.  Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.

Authors:  Su Yeon Lee; Eui Kyong Jeong; Min Kyung Ju; Hyun Min Jeon; Min Young Kim; Cho Hee Kim; Hye Gyeong Park; Song Iy Han; Ho Sung Kang
Journal:  Mol Cancer       Date:  2017-01-30       Impact factor: 27.401

10.  Chemokine (CC motif) ligand 18 upregulates Slug expression to promote stem-cell like features by activating the mammalian target of rapamycin pathway in oral squamous cell carcinoma.

Authors:  Hongfei Wang; Xueyi Liang; Mianxiang Li; Xiaoan Tao; Shanshan Tai; Zhaona Fan; Zhi Wang; Bin Cheng; Juan Xia
Journal:  Cancer Sci       Date:  2017-07-18       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.